share_log

Navco Pharmaceuticals Inc: 52109FV2 CERTIFICATION OF INTERIM FILINGS CEO EN

SEDAR ·  Jun 4, 2024 01:53
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more